FY2025 Earnings
Financial report interval: 2024.12.31 - 2025.12.31
Overview: Veraxa Biotech Holding AG(VRXA) the Revenue is 28.77 K (--%);the EBIT is -81.33 M (-149.5%);the EPS is -5.65 (-150.4%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.00B--
----
----
EBIT
-0.08B149.45%
----
----
EPS
-5.6526150.41%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf